Question 1

What is Wockhardt?

Accepted Answer

Wockhardt is a Company.

Question 2

How often does Wockhardt appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 18 articles.

Question 3

When was Wockhardt first tracked by Ergen?

Accepted Answer

First tracked on Dec 01, 2025.

Question 4

When was Wockhardt last mentioned in news?

Accepted Answer

Last active on Jun 01, 2026.

Question 5

What is Wockhardt's current news sentiment?

Accepted Answer

Aggregate sentiment score: 80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Wockhardt in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Wockhardt?

Accepted Answer

USFDA Accepts Wockhardt's Zaynich NDA (Dec 01, 2025, 9 articles).

Question 8

How did the "USFDA Accepts Wockhardt's Zaynich NDA" event impact Wockhardt?

Accepted Answer

Wockhardt's shares surged significantly after the US Food and Drug Administration accepted its New Drug Application for Zayn Malik, marking a historic achievement for the company and the Indian pharmaceutical industry.

Question 9

How did the "Wockhardt's Zaynich receives US FDA approval" event impact Wockhardt?

Accepted Answer

The company's shares rallied significantly due to the US FDA and CDSCO approvals for its novel antibiotic, Zayn Malik, strengthening its position in the global anti-infectives market and highlighting its innovation capabilities.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.